Effect of angiotensin II on microvascular permeability.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Surgical Research

• Publication date

  2002-05-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/JSRE.2002.6412PMID 12020123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signal transduction from the angiotensin II AT2 receptor.

  2000cited by this paper
• Differential role of angiotensin II receptor subtypes on endothelial superoxide formation

  2000cited by this paper
• Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation.

  2000cited by this paper
• Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells.

  1999cited by this paper
• Microvascular permeability.

  1999cited by this paper
• Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries.

  1999cited by this paper
• Potential mechanisms and physiologic actions of intracellular angiotensin II.

  1999cited by this paper
• Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle.

  1998cited by this paper
• Effects of AT1 and AT2 angiotensin receptor antagonists in angiotensin II-infused rats.

  1998cited by this paper
• Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle.

  1998cited by this paper
• Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.

  1996cited by this paper
• Modulation of membrane potential and ionic currents by the AT1 and AT2 receptors of angiotensin II.

  1996cited by this paper
• Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

  1995cited by this paper
• Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery.

  1995cited by this paper
• Molecular structure and function of angiotensin type 2 receptor.

  1994cited by this paper
• Vasoactive mediators and splanchnic perfusion

  1993cited by this paper
• Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension.

  1993cited by this paper
• Nonpeptide angiotensin II receptor antagonists.

  1991cited by this paper
• Nonpeptide angiotensin II receptor antagonists.

  1990cited by this paper
• Angiotensin receptors in pulmonary arterial and aortic endothelial cells.

  1989cited by this paper
• Trauma induced increases in plasma vasopressin and angiotensin II.

  1987cited by this paper
• Inhibition of vascular permeability changes in rats by captopril.

  1982cited by this paper
• Hormone and neurotransmitter receptors in an established vascular endothelial cell line.

  1976cited by this paper
• Effects of Angiotensin II and Some Analogues on Vascular Permeability in the Rabbit

  1972cited by this paper

• Vascular leakage during circulatory failure: physiopathology, impact and treatments

  2025cites this paper
• Insights into COVID-19 and Its Potential Implications for Kidney Dysfunction

  2023cites this paper
• Renalase: a novel regulator of cardiometabolic and renal diseases

  2022cites this paper
• Pharmacologic therapies of ARDS: From natural herb to nanomedicine

  2022cites this paper
• COVID-19–associated Lung Microvascular Endotheliopathy: A “From the Bench” Perspective

  2022cites this paper
• Damage to the Vascular Endothelium as a Leading Mechanism of COVID-19 Systemic Pathology

  2021cites this paper
• Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?

  2021cites this paper
• Vasopressor Support for Patients with Cardiopulmonary Failure

  2021cites this paper
• Fundamental Basis of COVID-19 Pathogenesis

  2020cites this paper
• COVID-19 and COPD: a narrative review of the basic science and clinical outcomes

  2020cites this paper
• ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19

  2020cites this paper
• Protective Effect of Phosphatidylserine Blockade in Hemorrhagic Shock.

  2020cites this paper
• Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

  2020cites this paper
• Protective effect of phosphatidylserine blockade in sepsis induced organ dysfunction.

  2019cites this paper
• Protective Effect and Mechanism of Alprostadil in Acute Respiratory Distress Syndrome Induced by Oleic Acid in Rats

  2018cites this paper
• Redox regulation of cardiovascular inflammation – Immunomodulatory function of mitochondrial and Nox‐derived reactive oxygen and nitrogen species

  2017cites this paper
• Angiotensin‐converting enzyme insertion/deletion gene polymorphism in Egyptian children with CAP: A case‐control study

  2017cites this paper
• Influence of Sanao Tang on urine volume and expression of aquaporin 2 in rats with respiratory function impairment induced by passive smoking and lipopolysaccharide.

  2016cites this paper
• Influence of Sanao Tang on urine volume and expression of aquaporin 2 in rats with respiratory function impairment induced by passive smoking and lipopolysaccharide.

  2016cites this paper
• prostacyclin release conductivity due to platelet-activating factor via Endothelin-1 attenuates increases in hydraulic

  2015cites this paper
• Valsartan Promoting Atherosclerotic Plaque Stabilization by Upregulating Renalase

  2015cites this paper
• Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice.

  2015cites this paper
• Treatment with Angiotensin-(1–7) reduces inflammation in carotid atherosclerotic plaques

  2014cites this paper
• Pharmacological therapies for acute respiratory distress syndrome

  2014cites this paper
• Chylomicrons combined with endotoxin moderate microvascular permeability

  2011cites this paper
• A Novel Role for Calpain in the Endothelial Dysfunction Induced by Activation of Angiotensin II Type 1 Receptor Signaling

  2011cites this paper
• Endothelin-1 attenuates increases in hydraulic conductivity due to platelet-activating factor via prostacyclin release.

  2011cites this paper
• Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS

  2011cites this paper
• Ghrelin decreases microvascular leak during inflammation.

  2010cites this paper
• Renin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsis

  2010cites this paper
• Pharmacological Therapy for Acute Lung Injury

  2010cites this paper
• ENDOTHELIN 1 AND PROSTACYCLIN ATTENUATE INCREASES IN HYDRAULIC PERMEABILITY CAUSED BY PLATELET-ACTIVATING FACTOR IN RATS

  2010cites this paper
• Lipoxin a(4) attenuates microvascular fluid leak during inflammation.

  2009cites this paper
• Pitavastatin, an HMG-CoA Reductase Inhibitor, Exerts eNOS-Independent Protective Actions Against Angiotensin II–Induced Cardiovascular Remodeling and Renal Insufficiency

  2008cites this paper
• Chapter 8 Reactive Oxygen Species and Endothelial Permeability

  2008cites this paper
• Ischemia-reperfusion injury in rats affects hydraulic conductivity in two phases that are temporally and mechanistically separate.

  2008cites this paper
• The discovery of angiotensin‐converting enzyme 2 and its role in acute lung injury in mice

  2008cites this paper
• Endothelin-1 reduces mesenteric microvascular hydraulic permeability via cyclic AMP and protein kinase A signal transduction.

  2007cites this paper
• Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak.

  2007cites this paper
• Angiotensin-converting enzyme 2 in acute respiratory distress syndrome

  2007cites this paper
• Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors

  2007cites this paper
• Angiotensin II type 2 receptor decreases ischemia reperfusion induced fluid leak.

  2007cites this paper
• Intracellular Signaling Pathways and Peroxisome Proliferator-Activated Receptors in Vascular Health in Hypertension and in Diabetes

  2007cites this paper
• Angiotensin-Converting Enzyme and Vascular Remodeling

  2007cites this paper
• Angiotensin-Converting Enzyme and Vascular Remodeling

  2007cites this paper
• Role of endothelin-1 and cyclic nucleotides in ischemia/reperfusion-mediated microvascular leak.

  2006cites this paper
• Angiotensin II subtype AT1 and AT2 receptors regulate microvascular hydraulic permeability via cAMP and cGMP.

  2006cites this paper
• The renin–angiotensin system in acute respiratory distress syndrome

  2006cites this paper
• Angiotensin II effect on hydraulic permeability: interaction with endothelin-1, nitric oxide, and platelet activating factor.

  2006cites this paper
• Systemic and regional hemodynamic effects of enalaprilat infusion in experimental normotensive sepsis.

  2006cites this paper
• Hydrolysis of Phosphatidylserine-exposing Red Blood Cells by Secretory Phospholipase A2 Generates Lysophosphatidic Acid and Results in Vascular Dysfunction*

  2006cites this paper
• Angiotensin II type 1 receptor activation increases microvascular permeability via a calcium dependent process.

  2005cites this paper
• Angiotensin II and vascular inflammation.

  2005cites this paper
• Endothelin-1 decreases postcapillary fluid efflux via prostacyclin release.

  2004cites this paper
• Endothelin-1 decreases microvessel permeability after endothelial activation.

  2004cites this paper
• Cyclic nucleotide second messengers (cAMP and cGMP) play a central role in signal transduction and regulation of mesenteric postcapillary fluid leak.

  2004cites this paper
• Angiotensin II type 2 receptor effect on microvascular hydraulic permeability.

  2004cites this paper
• Albumin impacts the effects of tonicity on microvascular hydraulic permeability.

  2004cites this paper
• Angiotensin II type 1 receptor activation increases microvascular hydraulic permeability.

  2004cites this paper
• Effect of hypertonic saline on microvascular permeability in the activated endothelium.

  2003cites this paper
• Dose-dependent actions and temporal effects of angiotensin II on microvascular permeability.

  2003cites this paper
• The Impact of Albumin on Hydraulic Permeability: Comparison of Isotonic and Hypertonic Solutions

  2003cites this paper